5673-99-4Relevant academic research and scientific papers
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
-
Page/Page column 2330; 2331, (2017/09/15)
Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
Condensation de reactifs organomagnesiens sur les bromhydrines du type R-CH(Br)-CH2OH. Influence des sels cuivreux.
Bourgain-Commercon, Monique,Normant, Jean F.
, p. 289 - 294 (2007/10/02)
Various allylic, vinylic and arylic Grignard reagents are able to condense with 2-bromo-1-alkanols in THF.The catalytic use of copper salts diminishes side reactions but is not required.
